These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2431023)

  • 1. Abnormalities of basophil "releasability" in atopic and asthmatic individuals.
    Plaut M; Kazimierczak W; Lichtenstein LM
    J Allergy Clin Immunol; 1986 Nov; 78(5 Pt 2):968-73. PubMed ID: 2431023
    [No Abstract]   [Full Text] [Related]  

  • 2. The concept of basophil releasability.
    Lichtenstein LM; MacGlashan DW
    J Allergy Clin Immunol; 1986 Feb; 77(2):291-4. PubMed ID: 2418091
    [No Abstract]   [Full Text] [Related]  

  • 3. Control mechanisms of human basophil releasability.
    Marone G; Poto S; Giugliano R; Celestino D; Bonini S
    J Allergy Clin Immunol; 1986 Nov; 78(5 Pt 2):974-80. PubMed ID: 2431024
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro histamine release from basophils of asthmatic and atopic individuals in D2O.
    Tung R; Lichtenstein LM
    J Immunol; 1982 May; 128(5):2067-72. PubMed ID: 6174620
    [No Abstract]   [Full Text] [Related]  

  • 5. Basophil histamine release and leukotriene production in response to anti-IgE and anti-IgE receptor antibodies. Comparison of normal subjects and patients with urticaria, atopic dermatitis or bronchial asthma.
    Bischoff SC; Zwahlen R; Stucki M; Müllner G; de Weck AL; Stadler BM; Dahinden CA
    Int Arch Allergy Immunol; 1996 Jul; 110(3):261-71. PubMed ID: 8688673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The heterogeneity of human IgE exemplified by the passive transfer of D2O sensitivity.
    MacDonald SM; White JM; Kagey-Sobotka A; MacGlashan DW; Lichtenstein LM
    Clin Exp Allergy; 1991 Jan; 21(1):133-8. PubMed ID: 1708690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human basophil releasability. II. Changes in basophil releasability in patients with atopic dermatitis.
    Marone G; Giugliano R; Lembo G; Ayala F
    J Invest Dermatol; 1986 Jul; 87(1):19-23. PubMed ID: 2425005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basophil releasability in the newborn: factors limiting immunoglobulin E-mediated histamine release.
    Mendoza GR; Minagawa K; Orner FB; Stiehm ER
    Pediatrics; 1982 Feb; 69(2):188-92. PubMed ID: 6173838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deuterium-oxide-induced histamine release from basophils of allergic subjects. I. Responsiveness to deuterium oxide requires an activation step.
    Kazimierczak W; Plaut M; Knauer KA; Meier HL; Lichtenstein LM
    Am Rev Respir Dis; 1984 Apr; 129(4):592-6. PubMed ID: 6201094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-Fc(episilon)RI auto antibodies and basophil histamine releasability in chronic idiopathic urticaria.
    Sabroe RA; Francis DM; Barr RM; Black AK; Greaves MW
    J Allergy Clin Immunol; 1998 Oct; 102(4 Pt 1):651-8. PubMed ID: 9802375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presence of IgG4 on the membrane of human basophils. Histamine release is induced by monoclonal antibodies directed against the Fab but not the Fc region of the IgG4 molecule.
    Jimeno L; Lombardero M; Carreira J; Moscoso Del Prado J
    Clin Exp Allergy; 1992 Nov; 22(11):1007-14. PubMed ID: 1281749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of IgE-dependent basophil releasability in allergic patients.
    Sanz ML; Latasa M; García BE; Gato JJ; Oehling A
    J Investig Allergol Clin Immunol; 1991 Oct; 1(5):293-301. PubMed ID: 1727011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Qualitative characteristics of histamine release from human basophils by covalently cross-linked IgE.
    Kagey-Sobotka A; Dembo M; Goldstein B; Metzger H; Lichtenstein LM
    J Immunol; 1981 Dec; 127(6):2285-91. PubMed ID: 6170694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on human basophil releasability.
    Marone G; Poto S; Giugliano R; Bonini S
    Int Arch Allergy Appl Immunol; 1985; 77(1-2):103-6. PubMed ID: 2409008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cord blood basophil releasability: a predictive marker for allergy?
    Miadonna A; Tedeschi A; Leggieri E; Motta G; Fabbri C; Lorini M; Lucci G; Froldi M; Marini A; Zanussi C
    Allerg Immunol (Paris); 1988 Feb; 20(2):45-7. PubMed ID: 2456082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of human basophil sulfidopeptide leukotriene release: releasability defined as the ability of the basophil to respond to dimeric cross-links.
    MacGlashan DW; Peters SP; Warner J; Lichtenstein LM
    J Immunol; 1986 Mar; 136(6):2231-9. PubMed ID: 2419427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basophil "releasability" in patients with asthma.
    Findlay SR; Lichtenstein LM
    Am Rev Respir Dis; 1980 Jul; 122(1):53-9. PubMed ID: 6157344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activated status of basophils in chronic urticaria leads to interleukin-3 hyper-responsiveness and enhancement of histamine release induced by anti-IgE stimulus.
    Lourenço FD; Azor MH; Santos JC; Prearo E; Maruta CW; Rivitti EA; Duarte AJ; Sato MN
    Br J Dermatol; 2008 May; 158(5):979-86. PubMed ID: 18341658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of basophil histamine release induced by the cross-linking of IgE receptors.
    Tanizaki Y; Komagoe H; Sudo M; Morinaga H; Kitani H; Kimura I
    Acta Med Okayama; 1985 Dec; 39(6):441-6. PubMed ID: 2418638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human basophil releasability. VI. Changes in basophil releasability in patients with allergic rhinitis or bronchial asthma.
    Casolaro V; Spadaro G; Marone G
    Am Rev Respir Dis; 1990 Nov; 142(5):1108-11. PubMed ID: 1700653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.